CEDAR KNOLLS, N.J.,
April 28, 2020 /PRNewswire/ -- MYOS
RENS Technology Inc. ("MYOS" or "the Company") (NASDAQ: MYOS), a
bionutrition company and the owner of
Fortetropin®, a proprietary
bioactive composition that helps build lean muscle, announced today
that its MYOS Canine Muscle Formula®
("MYOS Canine") Regular and Veterinarian
Strength, is now eligible for reimbursement by several
top-tier pet insurance companies.
The following pet insurers are now covering MYOS Canine
Muscle Formula: Nationwide Pet Insurance,
Trupanion Pet Insurance, Embrace Pet Insurance,
PetPlan Insurance, Hartville Pet Insurance/Petshealth
Care Plan, Prudent Pet Insurance, and PetPartners Pet
Insurance. Coverage is on a case-by-case basis and each
insurance company should be contacted in advance for details.
Veterinary expenses account for $58.5
billion in spending, annually, according to the North
American Pet Health Insurance Association (NAPHIA), and pet
insurers reimburse approximately $15.25
billion of those veterinary care costs, annually. Many
of these insurers also reimburse a large portion of the cost of
nutritional supplements when prescribed by a
veterinarian.
"I have been using Fortetropin in dogs for nearly 5 years. I
find it particularly helpful in older dogs and canines with muscle
atrophy," stated Leilani Alvarez,
DVM, DACVSMR, Director, Integrative & Rehabilitative Medicine,
Animal Medical Center, New York,
NY, an expert on veterinary nutraceuticals who is
well-published in this field. "It's rare to have veterinary
supplements backed by prospective clinical studies and,
Fortetropin, which has been studied rigorously, is a leader in this
regard," she added.
A vast number of human and veterinary clinical studies have
shown that gains in muscle mass and muscular strength are
associated with improved longevity for both humans and animals.
Additionally, specific veterinary clinical research has also shown
that Labrador Retriever dogs with greater muscle mass had
improved longevity.
"The decision by many veterinarians to recommend MYOS
Canine to their patients is a testament to the efficacy of
our product which is backed by high-caliber, published clinical
research," stated Joseph Mannello,
CEO of MYOS. "There is overwhelming evidence linking muscle health
to improved longevity, and we believe that MYOS Canine is an
excellent investment in your dog's muscle health. We will continue
to work with veterinarians and pet insurance companies to offer pet
owners a proven product to enhance their dog's muscle health."
About Myos Canine Muscle
Formula®
Myos Canine Muscle Formula
(Regular and Veterinarian Strength) is
an advanced veterinary health supplement to support muscle health
in dogs, featuring Fortetropin® as
the active ingredient. Fortetropin is made through a patented
process that maintains the vital nutrients of fertilized egg yolks
to help build more lean muscle and decrease muscle loss. For more
information, please visit www.myospet.com.
About MYOS RENS Technology Inc.
MYOS RENS Technology
Inc. (MYOS), "The Muscle Company®", is a
Cedar Knolls, NJ-based advanced
nutrition company that develops and markets products that improve
muscle health and performance. MYOS is the owner of
Fortetropin®, a fertilized egg
yolk-based product manufactured via a proprietary process to retain
and optimize its biological activity. Fortetropin has been
clinically shown to increase muscle size, lean body mass and reduce
muscle atrophy. MYOS believes Fortetropin has the potential to
redefine existing standards of physical health and wellness. For
more information, please visit www.myosrens.com.
Forward-Looking Statements
Any statements in
this release that are not historical facts are forward-looking
statements. Actual results may differ materially from those
projected or implied in any forward-looking statements. Such
statements involve risks and uncertainties, including but not
limited to those relating to product and customer demand, market
acceptance of our products, the ability to create new products
through research and development, the successful results of
strategic initiatives, the success of our products, including
MYOS Canine Muscle Formula®,
Yolked®, Physician Muscle
Health Formula®,
Qurr® and MYOS Enteral
Nutrition Formula™, the success of our
research and development, the results of the clinical evaluation
of Fortetropin® and its
effects, the ability to enter into new partnership opportunities
and the success of our existing partnerships, the ability to
generate revenue and cash flow from sales of our products, the
ability to increase our revenue and gross profit margins, the
ability to achieve a sustainable, profitable business, the effect
of economic conditions, the ability to protect our intellectual
property rights, competition from other providers and products, the
continued listing of our securities on the Nasdaq Stock
Market, risks in product development, our ability to raise capital
to fund continuing operations, the adverse impact of the
coronavirus on the economy and our business, and other
factors discussed from time to time in our filings with the
Securities and Exchange Commission. We undertake no obligation to
update or revise any forward-looking statement for events or
circumstances after the date on which such statement is made except
as required by law.
Investor Relations:
MYOS RENS Technology
Joanne Goodford
Phone: 973-509-0444
Email: jgoodford@myoscorp.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/myos-rens-announces-that-multiple-top-tier-pet-insurance-companies-now-cover-its-canine-nutrition-products-301047834.html
SOURCE MYOS RENS Technology Inc.